A detailed history of Quantinno Capital Management LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Quantinno Capital Management LP holds 157,560 shares of ABBV stock, worth $27.9 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
157,560
Previous 102,791 53.28%
Holding current value
$27.9 Million
Previous $17.6 Million 76.48%
% of portfolio
0.41%
Previous 0.32%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $8.97 Million - $10.9 Million
54,769 Added 53.28%
157,560 $31.1 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $118,723 - $138,642
767 Added 0.75%
102,791 $17.6 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $5.72 Million - $6.52 Million
35,789 Added 54.03%
102,024 $18.6 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $729,968 - $822,115
5,305 Added 8.71%
66,235 $10.3 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $2.9 Million - $3.35 Million
21,692 Added 55.28%
60,930 $9.08 Million
Q2 2023

Aug 04, 2023

SELL
$132.51 - $164.9 $781,013 - $971,920
-5,894 Reduced 13.06%
39,238 $5.29 Million
Q1 2023

May 03, 2023

BUY
$144.61 - $166.54 $504,833 - $581,391
3,491 Added 8.38%
45,132 $7.19 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $2.16 Million - $2.59 Million
15,636 Added 60.13%
41,641 $6.73 Million
Q3 2022

Nov 07, 2022

BUY
$134.21 - $153.93 $587,168 - $673,443
4,375 Added 20.23%
26,005 $3.49 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $601,261 - $764,400
4,369 Added 25.31%
21,630 $3.31 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $522,376 - $648,122
3,958 Added 29.75%
17,261 $2.8 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $1.43 Million - $1.81 Million
13,303 New
13,303 $1.8 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $602,592 - $724,488
-9,568 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $628,617 - $803,520
9,568 New
9,568 $696,000
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $334,401 - $393,574
-4,335 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $337,479 - $416,203
4,335 New
4,335 $400,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Quantinno Capital Management LP Portfolio

Follow Quantinno Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantinno Capital Management LP with notifications on news.